Q3 2026 Revenues of $268.3 million grew 9.1% compared to Q3 2025Net Loss of $61.8 millionAdjusted EBITDA of $162.0 million increased 4.4% compared to Q3 2025 (Adjusted EBITDA Margin of 60.4% versus 63.1% in Q3 2025)
MCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company, today announced that members of its management
MCLEAN, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company, today announced the launch of
MCLEAN, Va., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company, today announced that its Board of Directors
MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more
Claritev will support General Dynamics Information Technology by providing the Nationwide Provider Network for World Trade Center Responders and Survivors
Claritev Corporation (NYSE:CTEV), a healthcare technology,
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report.
The
Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights
Grants will support portable diagnostic technology in Illinois and continued access to specialist expertise on Kodiak Island
Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the
Expanded agreement builds on PHCS network access with pre- and post-payment integrity capabilities spanning the claims lifecycle
Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company,
Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025
Net Loss of $59.2 million
Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025
(Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that
New CMS data shows Claritev led all non-payer organizations in federal IDR volume while delivering outcomes above industry averages
Claritev achieved a 20% IDR success rate versus 12% industrywide, increasing to 24%
New solution combines claims-informed intelligence with AI-powered financial guidance to help employees make smarter benefits decisionsMCLEAN, Va. and WALTHAM, Mass., July 28, 2026 /PRNewswire/ -- Claritev
